All productsNAD+
Size
- 1000 mg — $80.00 CAD — Available
Research focus
A coenzyme involved in cellular metabolism, examined in a small human metabolite-tracking study.
In simple words
NAD+ is nicotinamide adenine dinucleotide, a coenzyme that helps cells carry out metabolic reactions. NAD+ is not a peptide; the selected small human study tracked metabolites rather than demonstrating reversal of ageing.
NAD+ is a coenzyme, not a peptide. Studies of NR or NMN are not automatically evidence for NAD+ itself.
Research references
Reviewed 2026-10-26
Human — small metabolic pilot
11 men: 8 in the NAD+ group and 3 controls.
Researchers measured plasma and urinary metabolites during and after an NAD+ infusion, documenting how the administered compound was processed.
This small, short metabolic study did not test longevity, cognitive improvement or disease prevention and cannot establish long-term safety. NAD+ is not interchangeable with its precursors NR or NMN.
PMID 31572171. Open full text checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Resources
Identity search; no unambiguous compound record assigned to this listing. Check forms and synonyms carefully.
PubChemMechanism and target search. Automated access returned 403; DrugBank was not used to substantiate claims or approval status.
DrugBankProtein/precursor search, not a record of the supplied vial. Synthetic compounds and lab supplies may have no matching protein entry.
UniProtBioactivity search. Assay results depend on the tested compound, target and experimental conditions.
ChEMBLExplore indexed literature. Search results are not supporting citations; selected verified publications appear above.
PubMedExplore registrations. A match or completed study does not establish efficacy, approval or relevance to this vial.
ClinicalTrials.govEvidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about NAD+
What is NAD+?
NAD+ is nicotinamide adenine dinucleotide, a coenzyme that helps cells carry out metabolic reactions. NAD+ is not a peptide; the selected small human study tracked metabolites rather than demonstrating reversal of ageing.
What types of research are cited for NAD+?
The NAD+ profile contains the following selected evidence. This is not a systematic review or a complete inventory of research.
NAD+ metabolism: pilot study (2019): Human — small metabolic pilot
Publication: NAD+ metabolism: pilot studyWho or what was studied in the selected NAD+ references?
NAD+ metabolism: pilot study (2019): 11 men: 8 in the NAD+ group and 3 controls.
Publication: NAD+ metabolism: pilot studyWhat identity distinctions matter for NAD+?
NAD+ is a coenzyme, not a peptide. Studies of NR or NMN are not automatically evidence for NAD+ itself.
What do the selected NAD+ studies not establish?
NAD+ metabolism: pilot study (2019): This small, short metabolic study did not test longevity, cognitive improvement or disease prevention and cannot establish long-term safety. NAD+ is not interchangeable with its precursors NR or NMN.
Publication: NAD+ metabolism: pilot studyThese studies do not establish the identity, purity, safety or effects of the MXC NAD+ vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.